Efficancy of EPA as prophylalaxis for venous thromboembolism in patients with underwent total knee arthroplasty

Efficancy of EPA as prophylalaxis for venous thromboembolism in patients with underwent total knee arthroplasty - Efficancy of EPA as prophylalaxis for venous thromboembolism in patients with underwent total knee arthroplasty

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022572

Enrollment

100

Registered

2016-06-01

Start date

2016-05-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

venous thromboembolism

Interventions

Take three capsules of EPA three times a day after meal for two weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Over twenty years old patients in TKA for the diagnosis of osteoarthritis

Exclusion criteria

Exclusion criteria: Patients with collagen disease,taking antiplatelet drugs,taking anticoagulant drugs,insulin therapy,drug allergy of EPA,hemorrhage,contrast media allergy ,detected DVT preoperative TKA

Design outcomes

Primary

Measure	Time frame
We examined patients underwent TKA with deep venous thrombosis in lower limbs using ultrasonography after EPA administration.	—

Countries

Japan

Contacts

Public ContactIshijima Muneaki

Juntendo University Graduate School of Medicine Department of Medicine for Orthopaedics and Motor Organ,

ishijima@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026